Skip to content
Latest
Ascend and M1X Global Complete First Institutional Repo on Stellar Using USDM1 Secured Sovereign Bond Is XRP Losing Ground to RLUSD at Ripple? CEO Brad Garlinghouse Responds You can’t rely on the S&P 500 as much as you may think ICE will take a stake in Trade xyz as regulated perpetual futures await US approval Nasdaq futures plunge 260 points: 5 things to know before Wall Street opens Lilly raises outlook for third time this year as Zepbound sales soar More than half of Türkiye’s crypto traders use AI to make investment decisions, study finds Samsung stock falls after record quarter as payout details slip to January Ascend and M1X Global Complete First Institutional Repo on Stellar Using USDM1 Secured Sovereign Bond Is XRP Losing Ground to RLUSD at Ripple? CEO Brad Garlinghouse Responds You can’t rely on the S&P 500 as much as you may think ICE will take a stake in Trade xyz as regulated perpetual futures await US approval Nasdaq futures plunge 260 points: 5 things to know before Wall Street opens Lilly raises outlook for third time this year as Zepbound sales soar More than half of Türkiye’s crypto traders use AI to make investment decisions, study finds Samsung stock falls after record quarter as payout details slip to January
STOX.NEWS
In focus
BTC 78 POST 63 HOOD 45 JST 31 NXTT 29 XRP 21 TLDR 20 PPLI 16

Lilly raises outlook for third time this year as Zepbound sales soar

MarketWatch
Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

The GLP-1 drug continues to dominate the market for prescription weight-loss drugs in the U.S.

Related video

Advertisement
Demo creative for ADG8 Article body (336x280)

More on this

Advertisement
Demo creative for ADG3 Footer banner (728x90)